Mianserin: Clinical Trials

4 trials of Mianserin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 unknown. 3 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1
Phase 31Terminated 1

Follow Mianserin: new trials by email Literature Review of Mianserin trials Research Report on Mianserin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems
Mianserin, Lorazepam - Depression
Phase 4UnknownZhenghui YI3002024-07-012024-06-27
Treatment of Sleep Disturbances in Trauma-affected Refugees
Mianserin, Imagery Rehearsal Therapy - Post Traumatic Stress Disorder, Depression
Phase 4CompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2412016-03-012019-09-16
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
C-ECT, PHARMACOTHERAPY - Depression
Phase 4TerminatedHospital Universitari de Bellvitge1042009-07-012015-08-31

Conditions studied

Depression (4)  ·  Anxiety Disorders (1)  ·  Dementia (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Stress Disorders, Post-Traumatic (1)

Sponsors

Hannover Medical School (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1)  ·  Zhenghui YI (1)

Countries

China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Spain (1)

Top investigators

Helge Frieling, Prof., MD (1)  ·  Hinuga Sandahl, MD. (1)  ·  Mikel Urretavizcaya Sarachaga, MD, PhD (1)

Results publications

PMID 29110681, PMID 33710347, PMID 33956223, PMID 39773112, PMID 40217415, PMID 41004514